Altimmune, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:ALT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -16.84 M-19.35 M-11.9 M-19.45 M-20.94 M -71.64 M Cash from investing activities -5.1 M101.11 M-149.32 M-79.16 M-3.69 M -131.06 M Cash from financing activities 34.12 M52.24 M39.35 M81.13 M78.47 M 251.2 M Free cash flow -16.84 M-19.35 M-11.9 M-19.45 M-20.94 M -71.64 M

News

After US-Iran Ceasefire 'Ends', Crypto and Stock Markets Suffer Widespread Declines

Altimmune: Pemvidutide AUD Data Due Q3 Makes For Intriguing Catalyst - Upgrade (ALT)

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker

5 Small Drug Stocks to Invest in Amid a Biotech Comeback

Why Is Altimmune (ALT) Down 11.3% Since Last Earnings Report?

Altimmune, Inc. (ALT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

ALT and the Rise of Dual Agonists Targeting Liver Disease

ALT Stock Guide to Pemvidutide's MASH, AUD and ALD Setup

Is Altimmune Worth Buying Ahead of 2026 Catalysts?

GLP-1 Sales Forecast Jumps To $150 Billion By 2030

Here's Why You Should Add Altimmune Stock to Your Portfolio Now

Altimmune's Q1 Loss Narrower Than Expected, Revenues Nil